Home » Collegium Pharmaceutical Announces FDA Approval of AllerNaze
Collegium Pharmaceutical Announces FDA Approval of AllerNaze
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has approved AllerNaze (triamcinolone acetonide, USP) Nasal Spray, 50 mcg, an aqueous based intranasal steroid indicated for the once daily treatment of nasal symptoms. …
Cloud Computing Journal
Cloud Computing Journal
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May